What is the dosage of Arcalyst?

Arcalyst is available in 1 dosages, including 220 mg Injection

What does Arcalyst treat?

Arcalyst treats Inflammation and Inborn Genetic Diseases

What is Arcalyst made of?

Arcalyst contains rilonacept which is a undefined

How is Arcalyst administered?

Arcalyst is administered as a Injectable

What is Arcalyst mechanism of action?

Arcalyst mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Arcalyst

(rilonacept)

rilonacept 220 MG Injection [Arcalyst]

NO BLACK BOX WARNING

Dosage & administration

Administer by subcutaneous injection

* CAPS, FCAS, MWS, and RP :
Adults:
* Loading dose: 320 mg, delivered as two 160 mg (2 mL) injections.
* Maintenance dose: 160 mg (2 mL) injection once weekly.
Pediatric patients 12 years to 17 years:
* Loading dose: 4.4 mg/kg, up to a maximum of 320 mg, delivered as 1 or 2 injections (not to exceed 2 mL/injection).
* Maintenance dose: 2.2 mg/kg, up to a maximum of 160 mg (2 mL) injection, once weekly.

* DIRA :
Adults and pediatric patients weighing 10 kg or more:
* 4.4 mg/kg up to a maximum of 320 mg, delivered as 1 or 2 injections (2 mL/injection) once weekly.

drug label

Arcalyst prescribing information

Have more Arcalyst questions?

Submit MSL Request

Learn More

Need to report an Arcalyst issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Arcalyst samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Arcalyst Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

Coverage Authorization Appeal

Appeal Letter Guide

Letter of Medical Neccessity Guide

Tiering Exception Letter

Tiering Exception Letter Guide

Learn More

Benefits investigation

Kinisa OneConnect Enrollment Form: Recurrent Pericarditis

Kinisa OneConnect Enrollment Form (Spanish): Recurrent Pericarditis

Kinisa OneConnect Enrollment Form: CAPS & DIRA

Kinisa OneConnect Enrollment Form (Spanish): CAPS & DIRA

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Arcalyst Financial assistance options

Co-pay savings program

commercial only

Kinisa OneConnect Enrollment Form: Recurrent Pericarditis

Kinisa OneConnect Enrollment Form (Spanish): Recurrent Pericarditis

Enroll in Patient Savings Program

Kinisa OneConnect Enrollment Form: CAPS & DIRA

Kinisa OneConnect Enrollment Form (Spanish): CAPS & DIRA

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Kinisa OneConnect Enrollment Form: CAPS & DIRA

Kinisa OneConnect Enrollment Form (Spanish): CAPS & DIRA

Quick Start Program: CAPS & DIRA

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Kinisa OneConnect Enrollment Form: Recurrent Pericarditis

Kinisa OneConnect Enrollment Form (Spanish): Recurrent Pericarditis

Patient Assistance Program

Kinisa OneConnect Enrollment Form: CAPS & DIRA

Kinisa OneConnect Enrollment Form (Spanish): CAPS & DIRA

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement